• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

HA15

CAS No. 1609402-14-3

HA15 ( HA15; HA-15; HA 15 )

产品货号. M17340 CAS No. 1609402-14-3

HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.

纯度: 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥381 有现货
5MG ¥616 有现货
10MG ¥786 有现货
25MG ¥1596 有现货
50MG ¥2811 有现货
100MG ¥4836 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    HA15
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
  • 产品描述
    HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
  • 同义词
    HA15; HA-15; HA 15
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    GRP78; HSPA5; BiP
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1609402-14-3
  • 分子量
    466.58
  • 分子式
    C23H22N4O3S2
  • 纯度
    98%
  • 溶解度
    DMSO : ≥ 50 mg/mL. 107.16 mM; H2O : < 0.1 mg/mL
  • SMILES
    CC(=O)Nc1nc(c2cccc(NS(=O)(=O)c3c4cccc(N(C)C)c4ccc3)c2)cs1
  • 化学全称
    N-(4-(3-((5-(dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Cerezo M et al. Cancer Cell. 2016 Jun 13;29(6):805-19.
产品手册
关联产品
  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • IPA-3

    IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6).